A Study of Sovilnesib in Subjects With Ovarian Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Sovilnesib in Subjects With Ovarian Cancer	Adnexal Diseases, Chromosomal Instability, Chromosome Aberrations, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Genomic Instability, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, primary peritoneal carcinoma	Active, not recruiting	Phase 1	2025-10-20		NCT06084416

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Volastra Therapeutics, Inc.	2

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Corewell Health	Grand Rapids	United States	45
Dana Farber Cancer Institute	Boston	United States	300
Fred Hutchinson Cancer Center	Seattle	United States	250
Georgia Cancer Center Augusta University	Atlanta	United States	1
Hoag Memorial Hospital	Newport Beach	United States	18
Icahn School of Medicine at Mount Sinai	New York	United States	7
Johns Hopkins Hospital	Baltimore	United States	135
MUSC Hollings Cancer Center	Charleston	United States	1
OU Health Stephenson Cancer Center	Oklahoma City	United States	14
Roswell Park Comprehensive Cancer Center	Buffalo	United States	63
The University of Alabama at Birmingham	Birmingham	United States	20
UCLA	Los Angeles	United States	80
University of Arkansas for Medical Sciences	Little Rock	United States	218